Future research should focus on illuminating how different interstitial lung disease subtypes affect outcomes in AAV. Interstitial lung disease (ILD) patterns differ between patients with ...

Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker which could help to detect disease progression ...

EULAR - The European Alliance of Associations for Rheumatology - has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...

Zongertinib showed a 71% overall response rate and 93% disease control rate in HER2-mutated NSCLC patients, with a median PFS of 12.4 months. No cases of interstitial lung disease were reported, even ...

In August 2025, the FDA gave accelerated approval to Hernexeos for patients with previously treated metastatic or ...

RILD in NHL patients presents as lung disease, organizing pneumonia, and nonspecific interstitial pneumonia, with 179 pathogenic microorganisms identified. The study systematically characterized RILD ...

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown. Stereotactic ablative radiotherapy (SABR) has ...

WHAT IS INTERSTITIAL LUNG DISEASE? Overview of Interstitial Lung Disease (ILD):Interstitial Lung Disease refers to a group of lung conditions that cause inflammation and scarring of the ...